ESC 365 - When do we need to anticoagulate in subclinical atrial fibrillation?

ESC Premium Access

When do we need to anticoagulate in subclinical atrial fibrillation?

Session: New Developments in Atrial Fibrillation, a Global Effort to Reduce the Burden of Cardiovascular Disease

Topic: Atrial Fibrillation (AF)

Speaker: Doctor T. Glotzer (Hackensack, US)

Event: ESC Congress 2020

Congress Presentation

Add to my library

About the speaker

Doctor Taya Glotzer

Hackensack University Medical Center, Hackensack (United States of America)

13 presentations

2 followers

2 more presentations in this session

Left atrial occluders in the world of NOAC.

Speaker: Professor M. Glikson (Jerusalem, IL)

Introducing an update to the WHF Roadmap on atrial fibrillation: a truly global effort.

Speaker: Professor S. Freedman (Sydney, AU)

Access the full session

New Developments in Atrial Fibrillation, a Global Effort to Reduce the Burden of Cardiovascular Disease

Speakers: Doctor T. Glotzer, Professor M. Glikson, Professor S. Freedman

About the event

ESC Congress 2020

29 August - 1 September 2020

Sessions Presentations

Congress

ESC 365 is supported by

bristol-myers-squibb

Explore sponsored resources

novartis

Explore sponsored resources